Fate of nanostructured lipid carriers (NLCs) following the oral route: design, pharmacokinetics and biodistribution
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Fate of nanostructured lipid carriers (NLCs) following the oral route: design, pharmacokinetics and biodistribution
Authors
Keywords
-
Journal
JOURNAL OF MICROENCAPSULATION
Volume 31, Issue 1, Pages 1-8
Publisher
Informa UK Limited
Online
2013-04-30
DOI
10.3109/02652048.2013.788090
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Design and evaluation of polymer coated carvedilol loaded solid lipid nanoparticles to improve the oral bioavailability: A novel strategy to avoid intraduodenal administration
- (2012) Vinay Kumar Venishetty et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Toward the Establishment of Standardized In Vitro Tests for Lipid-Based Formulations, Part 1: Method Parameterization and Comparison of In Vitro Digestion Profiles Across a Range of Representative Formulations
- (2012) Hywel D. Williams et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Nanosizing for oral and parenteral drug delivery: A perspective on formulating poorly-water soluble compounds using wet media milling technology
- (2011) Elaine Merisko-Liversidge et al. ADVANCED DRUG DELIVERY REVIEWS
- Recent Advances in Lipid Nanoparticle Formulations with Solid Matrix for Oral Drug Delivery
- (2010) Surajit Das et al. AAPS PHARMSCITECH
- Effects of lipophilic emulsifiers on the oral administration of lovastatin from nanostructured lipid carriers: Physicochemical characterization and pharmacokinetics
- (2010) Chih-Chieh Chen et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- New perspectives on lipid and surfactant based drug delivery systems for oral delivery of poorly soluble drugs
- (2010) Anette Müllertz et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Biodistribution and toxicity of nanodiamonds in mice after intratracheal instillation
- (2010) Xiaoyong Zhang et al. TOXICOLOGY LETTERS
- Lipid – An emerging platform for oral delivery of drugs with poor bioavailability
- (2009) Subhashis Chakraborty et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Lipid Nanoparticles with a Solid Matrix (SLN®, NLC®, LDC®) for Oral Drug Delivery
- (2008) Marc Muchow et al. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
- Short- and long-term stability study of lyophilized solid lipid nanoparticles for gene therapy
- (2008) A. del Pozo-Rodríguez et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs
- (2008) Arik Dahan et al. JOURNAL OF CONTROLLED RELEASE
- Drug Nanoparticles: Formulating Poorly Water-Soluble Compounds
- (2008) Elaine M. Merisko-Liversidge et al. TOXICOLOGIC PATHOLOGY
- Enhancing intestinal drug solubilisation using lipid-based delivery systems
- (2007) Christopher J.H. Porter et al. ADVANCED DRUG DELIVERY REVIEWS
- Approaches for the development of solid and semi-solid lipid-based formulations
- (2007) V. Jannin et al. ADVANCED DRUG DELIVERY REVIEWS
- Formulation of lipid-based delivery systems for oral administration: Materials, methods and strategies
- (2007) Colin W. Pouton et al. ADVANCED DRUG DELIVERY REVIEWS
- Biopharmaceutical challenges associated with drugs with low aqueous solubility—The potential impact of lipid-based formulations
- (2007) C.M. O'Driscoll et al. ADVANCED DRUG DELIVERY REVIEWS
- Lipid excipients and delivery systems for pharmaceutical development: A regulatory perspective
- (2007) Mei-Ling Chen ADVANCED DRUG DELIVERY REVIEWS
- Lipid-based delivery systems and intestinal lymphatic drug transport: A mechanistic update
- (2007) Natalie L. Trevaskis et al. ADVANCED DRUG DELIVERY REVIEWS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started